Medication Assisted Treatment (MAT) uses a combination of prescribed medications, such as buprenorphine (SUBUTEX), buprenorphine and naloxone (SUBOXONE) or naltrexone (VIVITROL) and comprehensive treatment services. These drugs can counter the effects of opioids on the brain or relieve withdrawal symptoms and cravings, helping the client avoid relapse.

Naltrexone is an antagonist medication that prevents other opioids from binding to and activating opioid receptors. It is used to treat overdose and addiction. An injectable, long-acting form of naltrexone (Vivitrol®) can be a useful treatment choice for patients struggling with opiate dependence as well as alcohol dependence. This medication is non-narcotic and is administered once monthly by a health care provider.

Buprenorphine is a partial opioid agonist – it binds to the opioid receptor but only partially activates it – that can be prescribed by certified physicians in an office setting. Like methadone, it can reduce cravings and is well tolerated by patients.

Buprenorphine and naloxone (SUBOXONE) is a once daily sublingual film used for the treatment of opiate dependence. Buprenorphine is an opioid medication, sometimes called a narcotic. Naloxone blocks the effects of opioid medication, including pain relief or feelings of well-being that can lead to opioid abuse.

Some clients, especially those who have had prior failed treatment attempts, may benefit from MAT. Each Pathways Florida client is assessed by a medical professional at the beginning of treatment and MAT options are discussed, if appropriate. Many of our clients find that by utilizing MAT, cravings are reduced and they are better able to focus on the counseling and education services provided in the program.